ABCB6 Mutations Cause Ocular Coloboma  by Wang, Lejing et al.
ARTICLE
ABCB6 Mutations Cause Ocular Coloboma
Lejing Wang,1,14,* Fei He,2,3,14 Juan Bu,1,14 Xiaqi Liu,2,3 Wei Du,1,13 Jiamei Dong,1,4
Jeffrey D. Cooney,5,6 Sushil Kumar Dubey,7 Yi Shi,2,3 Bo Gong,2,3 Jing Li,1 Paul F. McBride,5,6
Yanlei Jia,8 Fang Lu,2,3 Kathleen A. Soltis,5,6 Ying Lin,2,3 Prasanthi Namburi,7 Chen Liang,1
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Ocular coloboma is a developmental defect of the eye and is due to abnormal or incomplete closure of the optic fissure. This disorder
displays genetic and clinical heterogeneity. Using a positional cloning approach, we identified a mutation in the ATP-binding cassette
(ABC) transporter ABCB6 in a Chinese family affected by autosomal-dominant coloboma. The Leu811Val mutation was identified
in seven affected members of the family and was absent in six unaffected members from three generations. A LOD score of 3.2 at
q ¼ 0 was calculated for the mutation identified in this family. Sequence analysis was performed on the ABCB6 exons from 116 sporadic
cases of microphthalmia with coloboma (MAC), isolated coloboma, and aniridia, and an additional mutation (A57T) was identified in
three patients with MAC. These two mutations were not present in the ethnically matched control populations. Immunostaining of
transiently transfected,Myc-taggedABCB6 in retinal pigment epithelial (RPE) cells showed that it localized to the endoplasmic reticulum
and Golgi apparatus of RPE cells. RT-PCR of ABCB6mRNA in human cell lines and tissue indicated that ABCB6 is expressed in the retinae
and RPE cells. Using zebrafish, we show that abcb6 is expressed in the eye and CNS. Morpholino knockdown of abcb6 in zebrafish
produces a phenotype characteristic of coloboma and replicates the clinical phenotype observed in our index cases. The knockdown
phenotype can be corrected with coinjection of the wild-type, but not mutant, ABCB6mRNA, suggesting that the phenotypes observed
in zebrafish are due to insufficient abcb6 function. Our results demonstrate that ABCB6 mutations cause ocular coloboma.Introduction
Ocular coloboma (MIM 120200) is a developmental defect
of the eye and results from an abnormal or incomplete
fusion of the optic fissure. The defect can affect areas of
one or both of a patient’s eyes, including the cornea, iris,
ciliary body, lens, choroid, retina, and optic nerves.1 Clin-
ically, coloboma is often associated with microphthalmia
and anophthalmia in the eye or occurs as part of complex
malformation syndromes.1,2 The prevalence of coloboma
ranges from 0.5–7.5 per 10,000 births.3,4 Approximately
10% of childhood blindness is caused by severe coloboma-
tousmalformations.5 Coloboma can be caused by a genetic
mutation or by toxic environmental factors.1 At least 27
genes have been implicated in syndromes involving
coloboma,1,6–12 and PAX6 (MIM 607108), SHH (MIM
600725), GDF3 (MIM 606522), and RBP (MIM 180250)
have been shown by linkage and mutational screening to
cause isolated coloboma.7,13,14 Among the 27 coloboma-
associated genes, CHX10 (MIM 142993), MAF (MIM
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ocular disorders including microphthalmia, cataracts,
and microcornea. Mutations in other genes of this group
might lead to other birth defects in addition to ocular
coloboma.1,6–12,15 Current studies demonstrate that all
genes associated with coloboma play important roles in
the early development of the human body, especially in
the development of the CNS, including that of the eye.
To date, mutations in the genes described above can
explain approximately 50% of coloboma cases. Therefore,
additional genetic mutations responsible for a coloboma
phenotype still need to be identified.Subjects and Methods
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Figure 1. Mutations in ABCB6 and Clinical
Photographs of Patients with Coloboma
(A) Pedigree and segregation of the Leu811Val
mutation in the Chinese family affected by colo-
boma.
(B–E) Photographs of patients with coloboma are
compared to those of the unaffected individual.
The proband (II:5) of the Chinese family has iris
coloboma in the lower papillary margin (C) and
inferior chorioretinal coloboma (E). Photographs
of the normal iris (B) and fundus (D) of the unaf-
fected individual (II:9) in the same family are also
shown.
(F–H) Two mutations in ABCB6 and their
sequencing tracing, including Leu811Val (F) in
the Chinese family affected by coloboma and
Ala57Thr (G) in the three Indian patients who
have microphthalmia and coloboma. A partial
sequence of ABCB6 was compared with other
species’ orthologs (H). Arrows indicate the loca-
tion of the two mutations identified in patients
with ocular coloboma.Research Foundation and Aravind Eye Hospital. Informed consent
was obtained from all participants. All zebrafish studies were con-
ducted under the guidance and approval of the institutional
animal care and use committees at Children’s Hospital Boston
and Sichuan Provincial People’s Hospital.
Subjects
This study included oneHanChinese family affected by coloboma.
This family has 19 (17 living) familymembers (Figure 1A). The 600
normal controls are unrelated Han Chinese individuals from the
city of Beijing and the Chengdu region of the Sichuan province,
China, and they were recruited from the ophthalmology clinics
at PekingUniversityThirdHospital andSichuanProvincial People’sThe American Journal ofHospital. Additionally, 116 Indian coloboma-
affected patients came from the Tamil Nadu
region of India and were recruited from the
ophthalmology clinic at Aravind Eye Hospital.
We chose a separate control population of 200
normal DNA profiles that reflected the race and
ethnicity of the 116 coloboma subjects identified
in India and screened this population for the iden-
tifiedmutations. Prior to genetic testing, all partic-
ipants underwent an extensive, standardized
examination (performed by ophthalmologists),
which included visual-acuity testing, a detailed
clinical examination, optical coherence tomog-
raphy, and ocular imaging. All control individuals
underwent an eye exam and showed no signs of
coloboma or any other disease in either eye.
Mutation Screening
Peripheral blood was collected from the patients
and control subjects. Genomic DNA was isolated
with the salt-precipitation method. In the
Chinese index family, the disease was linked to
chromosomal region 2q35.There are 76 genes
and transcripts annotated in the critical interval.
Ten of these genes have been screened previously.Weperformed amutation screening of the remaining 66 genes and
transcripts byusinga direct sequencingof PCR-amplifiedDNAfrag-
ments for all exons. We purified these amplified DNA fragments
with the QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA,
USA), and we used forward and reverse primers to sequence them
with theBigDyeTerminator v3.1CycleSequencingKit (ABIApplied
Biosystems, Foster City, CA, USA) according to the manufacturer’s
instructions. The ABCB6 exons of the 116 additional cases from
Indiawere also analyzed via the direct sequencing of PCRproducts.
Sequence Alignments
WeusedClustalW(version1.83) to compareABCB6 (NP_005680.1)
with orthologs of P. troglodytes (XP_001161097.1), M. musculusHuman Genetics 90, 40–48, January 13, 2012 41
(NP_076221.1), R. norvegicus (NP_542149.1), D. melanogaster
(NP_650503.1), A. gambiae (XP_307900.4), and C. elegans
(NP_001022812.1).RT-PCR
We used RT-PCR to determine the expression levels of ABCB6 tran-
scripts in human cell lines, including D407 (retinal pigment
epithelial [RPE]) and human embryonic kidney (HEK) 293 cells.
We used these same techniques on human tissues to visualize
the expression pattern in the heart, retinae, RPE cells, lungs,
spleen, kidneys, and blood. These tissues were obtained from
a deceased 55-year-old Han Chinese male. Total RNA from the
human cell lines and tissues was extracted with Trizol (Invitrogen,
Carlsbad, CA, USA) and purified by chloroform extraction and iso-
propanol precipitation. Reverse transcription was performed with
a reverse-transcription kit (Invitrogen, Carlsbad, CA, USA). The
forward and reverse primers 50-GGTGGTGGGCAAGGGCAGAC-30
and 50-GGACGAAGTCCAGGGGCCCA-30, respectively, were used
with 100 ng of cDNA for PCR and gave a 432 bp product. The
housekeeping gene b-Actin, forward primer 50-AGCGAGCAT
CCCCCAAAGTT-30, and reverse primer 50-GGGCACGAAGGCTC
ATCATT-30 were used as an internal control to produce a 285 bp
product. All RT-PCR products were confirmed by direct
sequencing.
For zebrafish RT-PCR, we homogenized ten embryos in Trizol
reagent (Invitrogen, Carlsbad, CA, USA) by using a 25 gauge nee-
dle. We purified total RNA by chloroform extraction and isopropa-
nol precipitation. We synthesized cDNA from 500 ng of total RNA
by using a reverse-transcription kit (Invitrogen, Carlsbad, CA,
USA). Forward primer 50-GGAGTTGTACGGCGTGAGTT-30 and
reverse primer 50-ACGTCTCGCTCGTCTTCATT-30 were used with
100 ng of cDNA for PCR. The housekeeping gene b-Actin, forward
primer 50-GGACGCCATCCTGAAATA-30, and reverse primer
50-CCTGGGAGAACGGTAAAA-30 were used for PCR as an internal
control and gave a 411 bp product. DNA sequencing analysis
confirmed all PCR products.Cell Transfection
The forward 50-GGGGTACCCCATGGTGACTGTGGGCAACTAC-30
and reverse 50-TGCTCTAGAGCACCGTTCCATGGTCTGAGGC-30
primers contained KpnI and XbaI restriction sites, which were de-
signed for the amplification of WT ABCB6 cDNA. The amplified
cDNA was then digested with KpnI and XbaI and cloned into the
KpnI and XbaI sites of the pcDNA3.1(þ)/Myc-His A (Invitrogen,
Carlsbad, CA, USA) that included a Myc-His tag at the C terminus.
The Leu811Val and Ala57Thr mutations were introduced into the
WT ABCB6 pcDNA3.1(þ)/Myc-His A construct by PCR-based site-
directed mutagenesis. The recombinant plasmids were purified
with a QIAGEN plasmid isolation kit (QIAGEN, Valencia, CA,
USA) and were confirmed by restriction-enzyme digestion and
DNA sequencing.
Cultured D407 cells were propagated in Dulbecco’s Modified
Eagle Medium (Invitrogen, Carlsbad, CA, USA) with 10% fetal
bovine serum (Invitrogen, Carlsbad, CA, USA), 100 U/ml peni-
cillin, and 100 mg/ml streptomycin. We transfected the cells
with recombinant WT or mutant ABCB6 along with either
pDsRed2-ER (a marker specific to the endoplasmic reticulum
[ER]) or pDsRed2-Mito (a marker specific to mitochondria)
(Clontech Laboratories, Mountain View, CA, USA) by using
Lipofectamine Reagent 2000 according to the protocol of the
manufacturer (Invitrogen; Carlsbad, CA, USA).42 The American Journal of Human Genetics 90, 40–48, January 13, 2Immunostaining and Fluorescence Microscopy
of ABCB6 and Cell Compartments
We performed immunostaining by incubating the transferred
membrane with Myc monoclonal antibodies (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) overnight at 4C, and we then
detected the binding Myc antibody by using a second FITC-conju-
gated anti-mouse antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). For the Golgi apparatus colocalization study,
transfected cells were stained with anti-GM130, a Golgi apparatus
marker, per the protocol of the manufacturer (Sigma-Aldrich;
St. Louis, MO, USA). Images were collected with an Olympus
IX70 confocal laser-scanning microscope.
Zebrafish Husbandry
Adult and embryonic strains of albino and AB zebrafish were
maintained at 28.5C on a 14 hr light/10 hr dark cycle, and
embryos were produced by natural mating.
Whole-Mount RNA In Situ Hybridization in Zebrafish
We generated the digoxigenin-labeled antisense cRNA probes ac-
cording to the protocol of the manufacturer (Roche Applied
Science,Mannheim,Germany)byusing theabcb6cDNAtemplates.
The whole-mount in situ hybridization of albino embryos was per-
formed as previously described.16 Probe hybridizationwas detected
by color development with Pierce NBT/BCIP 1-Step Solution.
Gene Knockdown and Rescue in Zebrafish
abcb6ATG-inhibition (50-CACAGAAACTCTTCATCTCCACCAT-30)
(abcb6MO1), abcb6 splice-blocking (50-TGCTACCAGCAAGCG
TACCTGTTGC-30) (abcb6MO2), and standard control (50-CCTCTTA
CCTCAGTTACAATTTATA-30) morpholinos (MOs) were purchased
from Gene Tools (Philomath, OR, USA) and were injected into the
egg yolk of 1–2-cell-stage Oregon AB embryos. For rescue studies,
MOs were coinjected into 1–2-cell-stage zygotes with either wild-
type (WT) or mutant ABCB6 mRNA; these zygotes were expressed
in pcDNA3.1(þ)/Myc-His A and were purified by a scriptMAX
Thermo T7 Transcription Kit (Toyobo, Osaka, Japan).
Immunoblotting
To verify the ABCB6mRNA expression in the embryos, we homog-
enized ten embryos in a lysate buffer containing 1% Triton X-100,
0.01% SDS, 0.05 M Tris-HCl, and 0.001 M EDTA (pH 7.5). The
embryo lysates were centrifuged at 4000 rpm for 5 min, and super-
natants were used for electrophoresis in a 10% polyacrylamide gel.
The proteins were transferred to a polyvinylidene fluoride
membrane (Millipore, Billerica, MA) and were blocked for 1 hr at
room temperature with 5% skim milk in Tris-buffered saline con-
taining 0.05% Tween 20 (TBST). The membrane was incubated
overnight at 4C with the Myc monoclonal antibody and was
diluted 1:1000 in 5% milk containing TBST. It was then probed
with peroxidase-conjugated anti-mouse antibody (1:4000 dilution
in TBST, Amersham Biosciences, NJ, USA) for 1 hr and was devel-
oped with an ECL detection kit (Amersham Bioscience, NJ, USA)
according to the manufacturers’ protocol.Results
Identification of ABCB6 Mutations
We initially studied a large Chinese family with both
well-characterized iris coloboma in the lower papillary012
Figure 2. Subcellular Localization of ABCB6 in RPE Cells
Immunofluorescent images of the RPE cell that transiently
expresses Myc-tagged ABCB6 andmarkers for subcellular compart-
ments are shown. Neither WT nor mutant ABCB6, both in green,
colocalized with a mitochondrial maker, in red (A). Both WT and
mutant ABCB6, in green, colocalized with an ER marker, in red
(B), and with a Golgi maker, in red (C).margin and inferior chorioretinal coloboma17 (Figures
1A–1E). All of the known genes and/or loci associated
with coloboma were examined for mutations. When no
mutations in known coloboma-associated genes wereThe Amidentified, we then performed whole-genome linkage
analysis and mapped the disease-associated gene in our
index family to chromosomal region 2q35, as in our
previous report.17 There are 76 genes and transcripts
annotated within the identified interval. We sequenced
each exon of these 76 genes from the family’s proband
(II:5) (Figure 1A) and identified a single nucleotide change
in ABCB6 (MIM 605452) (c.2431C>G). This was the only
sequence change that completely cosegregated with the
disease phenotype in our index family (Figure 1A). This
nucleotide change was absent in DNA samples from 600
controls that were matched for Chinese ethnicity. The
nucleotide alteration results in a change of leucine to
valine at position 811 (Leu811Val) of ABCB6 (Figure 1F).
Given an autosomal-dominant mode of inheritance
with full penetrance and a disease allele frequency of
0.0001, we obtained a LOD score of 3.2 at q ¼ 0 for
this change.
We collaborated with our Indian colleagues, who had
a large cohort of DNA samples from subjects with a colo-
boma phenotype. Initially, we sequenced nine genes
(PAX6, SHH, GDF3, RBP, CHX10, MAF, SOX2, OTX2, and
RAX) previously shown to produce a coloboma phenotype
in 116 sporadic-coloboma samples obtained from patients
of Indian decent. These patients were known to have mi-
crophthalmia with iris and chorioretinal coloboma
(MAC) (63 cases), isolated coloboma (21 cases), and aniri-
dia (32 cases). No mutations were identified in these nine
genes in any of these samples.
We then sequenced the ABCB6 exons in these 116 DNA
samples. We identified a substitution in three unrelated
patients with coloboma. This substitution was absent in
a separate set of 200 DNA samples that were used as ethni-
cally matched controls. This mutation occurred in exon 1
(c. 169 G>A), and the nucleotide change resulted in an
alanine to threonine amino acid change at position 57
(Ala57Thr) of ABCB6 (Figure 1G). No additional sequence
changes were identified in the coding regions of the 76
genes within the disease interval mapped in this index
family. The two missense mutations identified in ABCB6
are located in a conserved region of the protein (Figure 1H).
We conclude that mutations in ABCB6 cause coloboma
and that ABCB6 is the gene we previously mapped to chro-
mosome 2 in our index family.16
ABCB6 Subcellular Localization in RPE Cells
We performed cotransfections of ABCB6 with markers for
the ER, mitochondria, and Golgi apparatus to identify
where in the D407 cells ABCB6 is localized. In RPE cells,
we found that both WT and mutant ABCB6 are located
primarily in the ER and Golgi apparatus (Figure 2). This
indicated that the alterations in ABCB6 do not affect the
protein’s subcellular localization for the majority of the
cells transfected with mutant ABCB6 constructs.
ABCB6 Expression in the Human Retina and RPE Cells
To investigate whether ABCB6 is expressed in the eye, we
examined ABCB6 expression in different human cell lines
and tissues by using RT-PCR. ABCB6 expression in retinalerican Journal of Human Genetics 90, 40–48, January 13, 2012 43
Figure 3. Expression of ABCB6 in Cell Lines and
Tissues and Whole-Mount RNA In Situ Hybrid-
ization in Zebrafish
(A) RT-PCR analyses of ABCB6 expression in
D407 and HEK 293 cells and the human spleen,
lungs, kidneys, heart, and blood gave a 435 bp
product. b-Actin was used as an internal control
for cDNA quantification and gave a 285 bp
product.
(B) Dorsal views of embryos from 24–72 hpf are
shown. WT (unstained) embryos were used as
controls. The transcript for abcb6 was expressed
in developing CNS tissue, including the eyes, at
24 hpf and later stages. The expression of abcb6
is detected circumferentially around the lens at
36 and 48 hpf. In addition, abcb6 is expressed
in developing pectoral fins.and RPE cells is much higher than in other tissues studied
(Figure 3A).
Morpholino Knockdown of abcb6 in Zebrafish
and Rescue Studies
To test the hypothesis that disruption of the normal func-
tionofABCB6cancausecoloboma,wedevelopedazebrafish
model to study eye development. We performed whole-
mount in situ hybridization to detect the expression of the
abcb6 transcript in early embryogenesis by using albino
strains, which lack melanin pigmentation. The abcb6 tran-
scripts are expressed in thedevelopingCNStissue, including
that of the eyes, at 24 hr postfertilization (hpf) and later
(Figure3B).Expressionofabcb6 is detectedcircumferentially
around the lens at 36 and 48 hpf (Figure 3B). This suggests
a function for abcb6 in eye development. In addition,
abcb6 is expressed in developing pectoral fins (Figure 3B).
We performed MO knockdown of abcb6 by using two
specific antisense oligonucleotides targeting abcb6. The first
antisense oligonucleotide blocks translation initiation by
targeting the 50 UTR through the first 25 bases of the coding
sequence of abcb6 (abcb6MO1). The second antisense oligo-
nucleotide modifies pre-mRNA splicing in the nucleus by
targeting splice junctionsofabcb6 (abcb6MO2). The standard44 The American Journal of Human Genetics 90, 40–48, January 13, 2012controlMOswere obtained fromGene Tools
(Philomath, OR, USA). We used RT-PCR and
DNA sequencing to verify the splicing alter-
ations for abcb6MO2 (Figure 4A).
We injected 250 zebrafish embryos with
either abcb6MO1, abcb6MO2, or control
MOs, and the embryos treated with either
abcb6MO1 or abcb6MO2 showed develop-
mental delay compared to those treated
with the control MOs (Figure 4E). After 36
hpf, coloboma-related eye defects, which
replicated the clinical phenotypes in our
patients, were observed in morphants
generated by both MOs (Figures 4E and 4F)
but were not seen in the control group
(Figures 4C and 4D). When zebrafish werestained with 40,6-diamidino-2-phenylindole, microscope
scanning showed that the defect caused by MO knock-
down of abcb6 translation was iris coloboma in the lower
papillary margin and resulted in a keyhole-like shape of
the pupil, as was seen in human patients in our index
family (Figure 5). The phenotype of altered eye develop-
ment induced by either of the abcb6-specific morpholinos
can be corrected when the embryos are coinjected withWT
ABCB6 (Figures 4G and 4H), but not with either of the
mutant ABCB6 mRNAs (Figures 4I–4L). Injection of either
abcb6MO1 or abcb6MO2 caused an abnormal ocular pheno-
type in 88% or 90% of the fish, respectively (Figure 4M).
Coinjection of WT ABCB6 mRNA with either abcb6MO1
or abcb6MO2 resulted in a normal phenotype in 85% or
86% of the fish, respectively, whereas coinjection with
the same amount of mutant ABCB6mRNA caused approx-
imately 25% of the fish to have a normal phenotype
(Figures 4G–4M). Immunoblotting with the Myc antibody
allowed us to verify that there were equal amounts of WT
and mutant ABCB6 translated from the injected mRNA in
the embryos (Figure 4B). These results demonstrate that
the effect is specifically caused by the knockdown of
endogenous abcb6 in zebrafish and suggests that the muta-
tions in ABCB6 might cause colobomas in humans.
Figure 4. Zebrafish Eye Development Disturbed by Knockdown
of abcb6 Expression and Rescue of abcb6 Morphants
(A) RT-PCR verified that abcb6MO2 altered normal abcb6 splicing
by deleting exon 2. This deletion results in an abnormal 268 bp
product as opposed to a normal 818 bp product.
(B) Immunoblotting with the Myc antibody verified that equal
amounts of abcb6 produced from the WT and mutant ABCB6
The AmIn the zebrafish studies, in which we knocked down
expression of abcb6, there was no observable phenotype,
such as fluorescence or porphyrin accumulation, that
would suggest a role forWTormutant abcb6 in tetrapyrrole
transport. In our studies, there was minimal staining for
abcb6mRNA expression in the developing liver and blood
island (intermediate cell mass), suggesting that if there is
a role for ABCB6 in erythroid development, it is minimal.
This would be contrary to what has been shown previously
for components of the heme biosynthetic pathway.Discussion
The formation and closure of the optic fissure requires
precisely coordinated sculpting and folding of the epithe-
lial tissue so that the edges of the optic fissure can align,
converge, and fuse. This early developmental process of
the eye is controlled by a complex network of transcrip-
tional factors, cell-cycle regulators, and diffusible signaling
molecules.18 Ocular coloboma occurs if optic closure is dis-
rupted as a result of poor regulation of this complex
network. Transcription factors such as PAX6, SOX2,
OTX2, RAX, and SIX3 interact and provide transcriptional
oversight to other coloboma-associatedmutations in genes
that play apivotal role in spatial and temporal development
of the eye.8,10–12,15,19 Here, we identified two mutations
(Leu811Val and Ala57Thr) in ABCB6. Comparative anal-
yses of ABCB6 with the same gene in other species showed
that Leu811 and Ala57 are highly conserved, implying that
these two residues are key to normal biological function.
The phenotype caused by disruption of ABCB6 might be
explained by haploinsufficiency for several reasons. (1)
The two identified mutations in ABCB6 are heterozygous
in our patients with coloboma (Figure 1B). (2) ABCB6 is ex-
pressed in the human eye, and abcb6 is expressed in the
zebrafishCNS, including the eyes. DecreasedmRNAexpres-
sion caused by morpholino knockdown in zebrafish repli-
cates the colobomaphenotype in the index cases. However,
approximately 50%of normalmRNAcan be detected in the
morphants at 48 hpf (Figure 4A). (3) Finally, the knock-
down phenotype can be corrected with the coinjection of
WT, but not mutant, ABCB6mRNA.
ABCB6 belongs to the ABC transporter family, which is
involved in the active transport of phospholipids, ions,mRNA were coinjected with MOs in zebrafish. b-Actin was used
as an internal control.
(C–L) Compared with zebrafish embryos treated with standard
control MOs (C and D), zebrafish embryos treated with
abcb6MO2 show coloboma and retarded development in 96 hpf
(E and F). These phenotypes can be rescued by the coinjection
of WT ABCB6 mRNA (G and H), but the phenotypes could not
be rescued by coinjection of the human mRNA containing either
the Leu811Val (I and J) or the Ala57Thr (K and L) mutation.
(M) Graph depicting the proportions of embryos with coloboma
associated with the injection of either abcb6MO1 or abcb6MO2
and the proportions rescued by coinjection with WT and mutant
ABCB6 mRNA.
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Figure 5. Iris Coloboma Produced by Morpho-
lino Knockdown of abcb6 in Zebrafish Compared
with the Patients with Coloboma in the Chinese
Family
(A) A normal iris is shown in an unaffected indi-
vidual in the same family as the control. (B) A
pupil shaped like a keyhole is seen in an affected
patient in the Chinese family afflicted with colo-
boma.
(C) The eye of a fish that was treated with
a control morpholino.
(D) Morphants treated with abcb6MO1 result in
a keyhole-shaped pupil similar to that seen in
the patients with coloboma.peptides, steroids, polysaccharides, amino acids, and bile
acids and can be used to transport nonphysiologic
compounds such as pharmaceutical drugs and other xeno-
biotic compounds.20–23 Previous studies have indicated
that mutations in 14 ABC transporters are associated
with 13 different Mendelian disorders, and genetic vari-
ants in ABC transporters are associated with complex
disorders in humans.20,24 Among these disorders, macular
dystrophy can be caused by mutations in ABCA4 (MIM
601691).25
The cellular localization of ABCB6 might be cell-type
dependent. Previous studies have indicated that ABCB6
localizes to the outer mitochondrial membrane26,27 and
is a mammalian mitochondrial porphyrin transporter.26
However, recent studies revealed that ABCB6 is glycosy-
lated inmultiple cell types and is also found in the classical
secretory pathway, which includes the ER, Golgi apparatus,
and plasma membrane.27,28 Consistent with these find-
ings, we found that ABCB6 localizes to the classical secre-
tory pathway, including the ER and Golgi complex, indi-
cating additional ABCB6 functions beyond its proposed
role as a porphyrin transporter in the mitochondria of
RPE cells.
In humans, ABCB7 (MIM 300135) and ABCB6
(MTABC3) have been identified as close homologs of
ATM1, implying a function of ABCB6 in the synthesis of
Fe-S clusters and/or iron homeostasis. Metal ions have
been shown to affect the development of the eye: Ca2þ,
Zn2þ, Mg2þ, and Fe2þ are essential trace elements
required for normal eye development. However, heavy
metals such as Ag, Au, Pb, and Hg are implicated in struc-
tural and physiological damage in the mammalian eye.
Therefore, it is possible that disruption of the normal bio-
logical functions of ABCB6 results in abnormal metal
homeostasis, which is detrimental to proper eye develop-46 The American Journal of Human Genetics 90, 40–48, January 13, 2012ment. During fetal development, retinoic
acid has a function in limb development
and formation of the heart, eyes, and
ears.29 Our hypothesis is that ABCB6 trans-
ports a signaling molecule involved in eye
development. Any alteration in specificity
or rate might lead to coloboma.Like PAX6 and SHH, ABCB6 is expressed elsewhere in the
developing CNS, but mutations in ABCB6 are mainly asso-
ciated with eye anomalies, presumably because ABCB6’s
function can be compensated for elsewhere in the CNS.1
Alternatively, the differential tissue requirements for
ABCB6 represent the demand for the metabolite that is
transported, and a 50% reduction is not enough to cause
abnormal development in the other tissues. Given that
abcb6 is expressed in the fin buds in zebrafish, it is possible
thatmutations in this gene cause, in addition to coloboma,
limb and/or skeletal anomalies comparable to the observed
phenotypes resulting from coloboma-associated genetic
mutations in GDF3 and GDF6 (MIM 601147).6,7
Defining the physiologic role of ABC transporter func-
tion will require further studies, including disease-specific
mutation screening, which links organs to specific pheno-
types, and mechanistic dissection of transporter function.
A directed screen to determine the role of ABCB6 in eye
development and to determine the mechanism leading to
ocular coloboma will provide important insight into devel-
opmental signaling that leads to optic malformations.Acknowledgments
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